Adalimumab treatment for chronic recurrent Vogt-Koyanagi-Harada disease with sunset glow fundus: A multicenter study

Masaru Takeuchi¹, Shunsaku Nakai¹, Yoshihiko Usui², Kenichi Namba³, Kayo Suzuki³, Yosuke Harada⁴, Sentaro Kusuhara⁵, Toshikatsu Kaburaki⁶, Rie Tanaka⁷, Masaki Takeuchi⁸, Nobuhisa Mizuki⁸, Kei Nakai⁹, Hiroshi Goto³, Carl P Herbort^10
1 Department of Ophthalmology, National Defense Medical College, Tokorozawa, Japan
² Department of Ophthalmology, Tokyo Medical University, Tokyo, Japan
³ Department of Ophthalmology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan
⁴ Department of Ophthalmology and Visual Science, Graduate School of Biomedical Sciences, Hiroshima University, Higashihiroshima, Japan
⁵ Department of Surgery, Division of Ophthalmology, Kobe University Graduate School of Medicine, Kobe, Japan
⁶ Department of Ophthalmology, Saitama Medical Centre, Jichi Medical University, Shimotsuke, Japan
⁷ Department of Ophthalmology, The University of Tokyo Hospital, Tokyo, Japan
⁸ Department of Ophthalmology and Visual Science, Graduate School of Medicine, Yokohama City University, Yokohama, Japan
⁹ Department of Ophthalmology, Yodogawa Christian Hospital, Osaka, Japan
¹⁰ Centre for Ophthalmic Specialized Care; University of Lausanne, Lausanne, Switzerland

Correspondence Address:
Masaki Takeuchi
Department of Ophthalmology, National Defense Medical College, 3-2 Namiki, Tokorozawa City, Saitama, 359-8513
Japan

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/sjopt.sjopt_204_22